EGY3 Antibody

Shipped with Ice Packs
In Stock

Description

Search Methodology

  • Databases Reviewed:

    • Antibody structure/function repositories (Sino Biological , eLife , PNAS )

    • Clinical antibody dynamics studies (The Lancet , PMC )

    • Therapeutic antibody registries

    • Antibody specificity databases (Histone Antibody Specificity Database )

    • Immune repertoire databases (OAS )

  • Search Terms:

    • "EGY3 Antibody"

    • "EGY3" + "immunoglobulin"

    • "EGY3" + "epitope"

Potential Explanations for the Absence of Data

  1. Nomenclature Variability:

    • "EGY3" may refer to:

      • A proprietary research compound not yet published

      • An internal identifier for a commercial antibody (e.g., anti-idiotype Type 1–3 antibodies )

      • A mistyped or outdated term (e.g., "EGFR" or "EGLN3" are known antibody targets)

  2. Research Stage:

    • If EGY3 is a novel antigen or antibody in preclinical development, it may lack publicly available data.

  3. Species Specificity:

    • No murine or human antibodies targeting "EGY3" are listed in the OAS database , which catalogs over 1 billion sequences.

Related Antibody Classes and Technologies

While EGY3-specific data are unavailable, the following antibody platforms could inform future research:

Antibody TypeRelevanceExample Technologies
Anti-idiotype AntibodiesDetect therapeutic antibodies via paratope binding Type 1 (non-blocking), Type 2 (blocking)
Neutralizing AntibodiesCritical for SARS-CoV-2 immunity Avidity maturation assays, ELISpot
High-Throughput ScreeningLinks antibody function to genetic data via NGS Membrane-bound Ig expression systems

Recommended Actions

  1. Verify Terminology: Confirm the correct spelling and context of "EGY3" (e.g., gene symbol, commercial catalog number).

  2. Explore Analogues: Investigate antibodies targeting similar epitopes (e.g., EGFR, EGR1) using platforms like the Histone Antibody Specificity Database .

  3. Utilize Screening Tools: Apply NGS-linked antibody discovery systems or deep learning predictors to characterize hypothetical EGY3 interactions.

Limitations

  • The search was constrained to English-language resources and pre-2025 publications.

  • Proprietary or non-indexed datasets (e.g., internal pharmaceutical research) were inaccessible.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
EGY3 antibody; Os03g0729000 antibody; LOC_Os03g51920 antibody; OsJ_12438 antibody; OSJNBb0011H13.3Probable zinc metalloprotease EGY3 antibody; chloroplastic antibody; EC 3.4.24.- antibody; Protein ETHYLENE-DEPENDENT GRAVITROPISM-DEFICIENT AND YELLOW-GREEN 3 antibody; OsEGY3 antibody
Target Names
EGY3
Uniprot No.

Target Background

Function
EGY3 Antibody targets a probable membrane-associated metalloprotease that may play a role in chloroplast development.
Database Links
Protein Families
Peptidase M50B family
Subcellular Location
Plastid, chloroplast membrane; Multi-pass membrane protein.

Q&A

What is EGY3 and why would researchers need antibodies against it?

EGY3 is a pseudoprotease located in the thylakoid membrane of plant chloroplasts that shares homology with the family of site-2-proteases (S2P). Unlike true S2P proteases which are found across all living organisms, EGY3 is unique to plants and has a highly conserved sequence throughout the plant kingdom . Researchers require specific antibodies against EGY3 to study its expression, localization, and interactions during stress responses, particularly during high light and high-temperature conditions where EGY3 expression is dramatically induced . EGY3 antibodies enable detailed investigation of its functional role in photosystem I and light-independent reactions of photosynthesis.

How can I verify the specificity of an EGY3 antibody?

To verify EGY3 antibody specificity, a multi-faceted approach is recommended:

  • Western blot validation: Compare protein extracts from wild-type plants versus egy3 knockout mutants. A specific antibody will show bands at the expected molecular weight (~39 kDa) in wild-type samples but not in knockout mutants.

  • Immunoprecipitation followed by mass spectrometry: This approach can confirm that the antibody captures EGY3 from complex protein mixtures. Mass spectrometric analysis should identify unique peptides spanning the complementarity determining regions (CDRs) with high uniqueness scores (>80%) .

  • Immunolocalization studies: EGY3 antibodies should specifically label thylakoid membranes in chloroplasts, consistent with the known subcellular localization of the protein .

  • Cross-reactivity testing: Test the antibody against recombinant EGY3 and related S2P proteases to ensure it specifically recognizes EGY3 and not related family members.

What are the optimal storage conditions for EGY3 antibodies?

EGY3 antibodies should be stored according to standard antibody preservation protocols to maintain binding efficacy:

  • Store antibody aliquots at -20°C for long-term storage or at 4°C for short-term use (1-2 weeks)

  • Add glycerol (50% final concentration) for freeze-thaw stability if multiple uses are anticipated

  • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

  • Consider adding preservatives like sodium azide (0.02%) for solutions stored at 4°C

  • Document storage conditions and monitor antibody performance over time to establish batch-specific stability profiles

How should I design experiments to study EGY3 expression under stress conditions?

When designing experiments to study EGY3 expression under stress conditions, consider the following methodological approach:

  • Time-course analysis: EGY3 expression dramatically increases during the first few hours of exposure to high light and high-temperature stress . Design time-course experiments (0, 1, 3, 6, 12, 24 hours) to capture both immediate and sustained responses.

  • Stress parameters: For high light stress, use 600-800 μmol photons m⁻² s⁻¹ (compared to normal growth conditions of ~150 μmol photons m⁻² s⁻¹). For high-temperature stress, expose plants to 37-40°C (compared to normal growth at 21-23°C).

  • Complementary techniques: Combine transcript analysis (real-time PCR) with protein accumulation studies (Western blot using EGY3 antibodies) to correlate gene expression with protein levels .

  • Controls: Include both positive controls (known stress-responsive proteins) and negative controls (egy3 mutant plants) to validate antibody specificity and experimental conditions.

  • Physiological parameters: Measure hydrogen peroxide levels and CSD2 (copper/zinc superoxide dismutase 2) protein abundance simultaneously, as these have been shown to be affected in egy3 mutants during stress conditions .

What are the recommended antibody concentrations for different experimental applications with EGY3?

ApplicationRecommended DilutionIncubation ConditionsNotes
Western Blot1:1000 - 1:50002 hours at RT or overnight at 4°CUse 5% non-fat milk in TBST as blocking agent
Immunoprecipitation2-5 μg per 500 μg protein lysate2-4 hours at 4°CPre-clear lysates to reduce background
Immunohistochemistry1:100 - 1:500Overnight at 4°CAntigen retrieval may improve signal
ELISA1:500 - 1:20001-2 hours at RTOptimize coating concentration of capture antibody
ChIP2-5 μg per reactionOvernight at 4°CInclude appropriate controls for specificity

Note: These are starting recommendations. Optimal concentrations should be determined empirically for each antibody lot and experimental system.

How can I troubleshoot weak or absent signals when using EGY3 antibodies?

When troubleshooting weak or absent signals in experiments using EGY3 antibodies, consider these methodological approaches:

  • Sample preparation:

    • Ensure complete protein extraction from thylakoid membranes (where EGY3 is localized)

    • Use detergents appropriate for membrane proteins (e.g., n-dodecyl β-D-maltoside)

    • Include protease inhibitors to prevent degradation

  • Antibody validation:

    • Confirm antibody reactivity using recombinant EGY3 protein as a positive control

    • Verify antibody storage conditions haven't compromised activity

    • Consider testing multiple antibody clones targeting different epitopes

  • Signal enhancement strategies:

    • Increase antibody concentration or incubation time

    • Use more sensitive detection systems (e.g., chemiluminescence amplification)

    • Apply antigen retrieval techniques for fixed samples

    • Consider using secondary antibody enhancement systems

  • Experimental considerations:

    • Ensure stress conditions adequately induce EGY3 expression (peak expression occurs within first few hours of stress)

    • Check for post-translational modifications that might affect epitope recognition

    • Consider protein-protein interactions that could mask antibody binding sites

How can I use EGY3 antibodies to investigate protein-protein interactions in stress response pathways?

For investigating protein-protein interactions involving EGY3 during stress responses, employ these methodological approaches:

  • Co-immunoprecipitation (Co-IP):

    • Use EGY3 antibodies to precipitate the protein complex from stressed plant tissue

    • Analyze precipitated proteins by mass spectrometry to identify interaction partners

    • Compare results from different stress conditions (high light vs. high temperature) to identify stress-specific interactions

    • Validate key interactions with reciprocal Co-IP using antibodies against identified partners

  • Proximity labeling approaches:

    • Generate plants expressing EGY3 fused to a proximity labeling enzyme (BioID or APEX)

    • Apply stress conditions and activate labeling to identify proximal proteins

    • Use EGY3 antibodies to verify proper expression and localization of fusion proteins

  • In situ proximity ligation assay (PLA):

    • Apply PLA using EGY3 antibody paired with antibodies against potential interaction partners

    • This technique can visualize protein interactions in their native cellular context

    • Quantify interaction signals under different stress conditions

  • Integration with functional data:

    • Focus on proteins related to RubisCO folding, glycine metabolism, and photosystem I components, which have been identified as differentially accumulating in egy3 mutants

    • Correlate interaction data with hydrogen peroxide levels and CSD2 abundance to establish functional relationships

What considerations should be made when using EGY3 antibodies for epitope specificity across plant species?

When using EGY3 antibodies across different plant species, the following methodological considerations are critical:

  • Sequence conservation analysis:

    • EGY3 sequence is highly conserved across the plant kingdom , making cross-species applications feasible

    • Perform sequence alignments to identify conserved regions that could serve as universal epitopes

    • Design or select antibodies targeting highly conserved epitopes for cross-species applications

  • Validation in target species:

    • Despite sequence conservation, always validate antibody reactivity in each target species

    • Use Western blot to confirm band size and specificity in each species

    • When possible, include genetic controls (knockouts or knockdowns) in the target species

  • Epitope mapping considerations:

    • Consider using antibody inference and design approaches for optimizing specificity

    • Computational models can predict antibody binding modes for different species variants

    • Custom antibody design may be needed for species with significant epitope variations

  • Cross-reactivity assessment:

    • Test antibodies against recombinant EGY3 proteins from multiple species

    • Evaluate potential cross-reactivity with related S2P proteases in the target species

    • Consider competitive binding assays to determine relative affinity across species variants

How can I combine EGY3 antibody-based studies with proteomics to understand stress-induced protein dynamics?

To effectively integrate EGY3 antibody studies with proteomics for understanding stress-induced protein dynamics:

  • Immunoprecipitation-mass spectrometry (IP-MS):

    • Use EGY3 antibodies to enrich for EGY3 and its interacting partners

    • Apply improved mass spectrometric methods with both trypsin and chymotrypsin digestion to enhance sequence coverage

    • Implement subslicing of SDS-PAGE separated bands before MS to enable greater correlation between peptides

    • Use offline high pH reversed phase peptide fractionation to decrease sample complexity and enhance sensitivity

  • Quantitative proteomics approaches:

    • Apply SILAC, TMT labeling, or label-free quantification to compare protein abundances under different stress conditions

    • Focus analysis on proteins identified as differentially accumulating in egy3 mutants, particularly those related to photosystem I, RubisCO folding, and glycine metabolism

    • Correlate proteomic changes with physiological parameters like hydrogen peroxide levels and photosynthetic efficiency

  • Temporal dynamics analysis:

    • Design time-course experiments to capture the progression of stress responses

    • Use EGY3 antibodies to monitor protein accumulation patterns in parallel with global proteome changes

    • Implement computational modeling to identify protein interaction networks evolving during stress

  • Subcellular localization studies:

    • Combine EGY3 immunolocalization with organelle-specific proteomic analysis

    • Focus on thylakoid membrane proteome changes, where EGY3 is localized

    • Investigate potential translocation events during stress responses

How do antibody responses to EGY3 compare with responses to other chloroplast stress proteins?

When comparing antibody-based detection of EGY3 with other chloroplast stress proteins:

  • Expression kinetics comparison:

    • EGY3 expression is dramatically induced during the first few hours of high light and high-temperature stress

    • Compare this with the expression patterns of other stress proteins using a standardized panel of antibodies

    • Create a temporal map of stress protein induction to place EGY3's role in the broader stress response timeline

  • Subcellular localization differences:

    • EGY3 is specifically localized to thylakoid membranes

    • Use co-localization studies with antibodies against other compartment-specific markers to determine spatial relationships between stress response proteins

    • Quantify co-localization coefficients to measure association strength between EGY3 and other proteins

  • Functional correlation analysis:

    • EGY3's role appears to be associated with photosystem I rather than photosystem II

    • Compare antibody-based quantification of EGY3 with photosystem components and other stress proteins

    • Correlate protein levels with physiological parameters like hydrogen peroxide levels and photosynthetic efficiency

  • Phylogenetic perspective:

    • Unlike many stress response proteins, EGY3 is unique to plants

    • Compare antibody cross-reactivity patterns across species for EGY3 versus conserved stress proteins

    • This can provide insights into the evolutionary specialization of plant stress responses

What methodological approaches can resolve discrepancies in EGY3 antibody-based research findings?

To address discrepancies in research findings using EGY3 antibodies, consider these methodological approaches:

  • Antibody characterization and standardization:

    • Thoroughly validate antibody specificity using multiple methods (Western blot, IP-MS, immunohistochemistry)

    • Consider antibody batch variability; characterize each batch with standardized positive controls

    • Implement the inference and design of antibody specificity approaches to create reagents with well-defined binding properties

  • Experimental condition harmonization:

    • Standardize stress protocols (intensity, duration, plant developmental stage)

    • Document precise growth conditions as minor variations can affect stress responses

    • Create detailed protocols for sample collection, processing, and preservation

  • Multi-method validation:

    • Verify antibody-based findings with complementary techniques:

      • Correlate protein levels (antibody detection) with transcript levels (qPCR)

      • Confirm localization with both antibodies and fluorescent protein fusions

      • Validate protein interactions with multiple independent methods

  • Genetic controls implementation:

    • Include egy3 knockout mutants as negative controls

    • Use complementation lines expressing EGY3 variants to confirm specificity

    • Consider dosage effects with overexpression lines

  • Systematic error analysis:

    • Create a table documenting potential sources of variation in EGY3 research:

Variable FactorPotential ImpactStandardization Approach
Plant ageVariable EGY3 expressionUse plants at consistent developmental stage (e.g., 21-day-old rosettes)
Light intensity during stressAffects induction kineticsCalibrated light sources with precise photon flux measurement
Temperature fluctuationsAlters stress response timingControlled growth chambers with continuous monitoring
Protein extraction methodDifferential recovery of membrane proteinsStandardized protocol optimized for thylakoid membrane proteins
Antibody batch variationInconsistent sensitivityInclude standard curve with recombinant protein for quantification
Image analysis parametersQuantification discrepanciesOpen-source analysis pipelines with defined thresholds

How can EGY3 antibodies contribute to understanding reinfection immunity mechanisms in plants?

While EGY3 is primarily studied in the context of abiotic stress responses, antibodies against this protein could contribute to understanding plant immune memory and reinfection responses:

  • Potential parallels with immune system memory:

    • Similar to how previous SARS-CoV-2 infection induces effective immunity to future infections in most individuals , plants also develop systemic acquired resistance

    • EGY3 antibodies could help investigate whether this pseudoprotease plays a role in "stress memory" or priming mechanisms

    • Monitor EGY3 protein levels during primary stress exposure and subsequent challenges to assess potential memory effects

  • Cross-stress protection mechanisms:

    • Investigate whether high light or temperature stress affects subsequent pathogen resistance

    • Use EGY3 antibodies to monitor protein dynamics during sequential or combined stresses

    • Correlate EGY3 levels with hydrogen peroxide production, which functions as a signaling molecule in both abiotic and biotic stress responses

  • Methodological approach for memory studies:

    • Apply initial stress treatment (high light or temperature)

    • Allow recovery period of varying duration

    • Apply secondary stress (same or different type)

    • Use EGY3 antibodies to track protein dynamics throughout this sequence

    • Correlate with physiological parameters and transcriptomic changes

  • Integration with emerging concepts in immunity:

    • Explore potential connections between EGY3's role and concepts from mammalian immunity

    • While direct parallels must be approached cautiously, concepts like trained immunity and cellular memory could inform experimental design

    • The persistence of stress protection in plants could have mechanistic similarities to how previous infection induces effective immunity to future infections

How might new antibody technologies enhance EGY3 research beyond current capabilities?

Emerging antibody technologies offer significant potential for advancing EGY3 research:

  • Single-domain antibodies (nanobodies):

    • The small size of nanobodies (15 kDa) provides advantages for accessing restricted epitopes within membrane complexes

    • The improved mass spectrometric analysis methodology for nanobody generation could be applied to create highly specific EGY3-targeting reagents

    • These could enable better access to EGY3 within the crowded thylakoid membrane environment

  • Bispecific antibodies for co-localization studies:

    • Develop bispecific antibodies that simultaneously target EGY3 and suspected interaction partners

    • This would enable direct visualization of protein complexes in their native environment

    • Engineering of CH3 domains for heterodimerization could enable creation of such tools

  • Antibody-based biosensors:

    • Create split-reporter systems fused to anti-EGY3 antibody fragments

    • These could provide real-time monitoring of EGY3 conformational changes or interactions during stress responses

    • Potential for in vivo imaging of EGY3 dynamics during stress progression

  • Computational design of antibody specificity:

    • Apply biophysics-informed models to identify and disentangle multiple binding modes associated with specific ligands

    • This approach could generate antibodies with customized specificity profiles for EGY3

    • Particularly valuable for distinguishing between different conformational states of EGY3 during stress response

What are the most promising applications of EGY3 antibodies for studying plant-microbe interactions?

Although EGY3 has primarily been studied in the context of abiotic stress, its antibodies offer potential insights into plant-microbe interactions:

  • Pathogen-induced stress responses:

    • Use EGY3 antibodies to investigate whether pathogen infection alters EGY3 expression or localization

    • Compare EGY3 dynamics during abiotic stress versus pathogen challenge

    • Determine if pathogens that target chloroplast function affect EGY3 levels

  • Role in reactive oxygen species (ROS) signaling networks:

    • EGY3 mutants show altered hydrogen peroxide levels during stress

    • ROS are crucial signaling molecules in both abiotic stress and pathogen responses

    • Use EGY3 antibodies to track protein dynamics during ROS-dependent defense responses

  • Beneficial microbe interactions:

    • Investigate whether plant-growth-promoting microbes affect EGY3 expression

    • Study potential roles in chloroplast-mediated systemic resistance induced by beneficial microbes

    • Compare EGY3 protein levels in plants with established mycorrhizal or rhizobial associations

  • Methodological approach for microbe studies:

    • Establish standardized pathogen infection or beneficial microbe colonization protocols

    • Use EGY3 antibodies in time-course studies to track protein dynamics

    • Combine with physiological measurements and transcriptomic analysis

    • Include egy3 mutants to determine functional relevance of observed changes

How can structural insights from antibody interfaces improve EGY3 functional studies?

Leveraging structural information from antibody interfaces can significantly enhance EGY3 functional studies:

  • Epitope mapping for functional domain identification:

    • Generate a panel of antibodies targeting different EGY3 epitopes

    • Correlate epitope recognition with functional effects (e.g., which antibodies inhibit stress-related functions)

    • Use information from recurrent antibody interface clusters to guide epitope selection

  • Conformational state detection:

    • Design conformation-specific antibodies that recognize EGY3 in different functional states

    • Apply knowledge from antibody interfaces to optimize recognition of specific structural features

    • This could reveal if EGY3 undergoes conformational changes during stress responses

  • Structure-guided antibody engineering:

    • Apply insights from natural antibody interfaces to design improved research tools

    • Target the most prevalent interface clusters identified through structural mining

    • Consider the diverse representation of species, LC, and Fv subgroups in designing broadly applicable tools

  • Comparative structural biology approach:

    • Use antibodies as crystallization chaperones to obtain EGY3 structural information

    • Compare EGY3 structure with true S2P proteases to understand functional differences

    • The antibody interfaces revealed through structural mining could provide templates for designing crystallization-promoting antibodies

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.